General MedicationsTOPICALGeneric
PREDNICARBATE
PREDNICARBATE
Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview PREDNICARBATE is listed in Drugs@FDA under application 077287 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient PREDNICARBATE Form and strength CREAM;TOPICAL - 0.1% Sponsor FOUGERA PHARMS Submission history Latest submission status date: 2015-10-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview PREDNICARBATE is listed in Drugs@FDA under application 077287 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PREDNICARBATE Form and strength CREAM;TOPICAL - 0.1% Sponsor FOUGERA PHARMS Submission history Latest submission status date: 2015-10-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.